Assignment Agreements in the Pharmaceuticals Industry

157 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (4 contracts)
Accelerated Pharma, Inc. (4)
ACELRX PHARMACEUTICALS INC (2)
Aclaris Therapeutics, Inc. (3)
Aegerion Pharmaceuticals, Inc. (1)
Akers Biosciences, Inc. (2)
Akorn (1)
Ampio Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (3)
ANI Pharma Inc (1)
Apimeds Pharmaceuticals US, Inc. (2)
Applied BioSciences Corp. (2)
ARIAD PHARMACEUTICALS INC (1)
Assertio Therapeutics, Inc (2)
Astex Pharmaceuticals, Inc (2)
AVADEL PHARMACEUTICALS PLC (1)
Bakhu Holdings, Corp. (1)
Baudax Bio, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (4)
BioPharmX Corp (1)
Boston Therapeutics, Inc. (3)
Braeburn Pharmaceuticals, Inc. (1)
Bristol-Myers Squibb (2)
CALLISTO PHARMACEUTICALS INC (1)
Canopy Growth Corp (2)
CARDAX, INC. (1)
Catalent Inc (1)
Cocrystal Pharma, Inc. (1)
CorMedix Inc. (1)
CUMBERLAND PHARMACEUTICALS INC (1)
ELITE PHARMACEUTICALS INC (2)
Eloxx Pharmaceuticals, Inc. (1)
Endo Pharmaceuticals Solutions Inc. (1)
EPIX Pharmaceuticals, Inc. (1)
Evofem Biosciences, Inc. (1)
Exactus, Inc. (1)
EYEGATE PHARMACEUTICALS INC (1)
GB SCIENCES INC (2)
Horizon Pharma plc (2)
Hoth Therapeutics, Inc. (1)
Jaguar Health, Inc. (2)
Jazz Pharmaceuticals plc (5)
Lexaria Bioscience Corp. (7)
Lowell Farms Inc. (2)
MAP Pharmaceuticals, Inc. (1)
MARINUS PHARMACEUTICALS INC (1)
MIRA PHARMACEUTICALS, INC. (1)
Nabriva Therapeutics plc (1)
Neuralstem, Inc. (2)
NEW RIVER PHARMACEUTICALS INC (3)
NewBridge Global Ventures, Inc. (1)
Notis Global, Inc. (2)
NovaBay Pharmaceuticals, Inc. (1)
NPS PHARMACEUTICALS INC (2)
OMEROS CORP (2)
OPTIMER PHARMACEUTICALS INC (2)
OSCIENT PHARMACEUTICALS CORP (2)
Pacira Pharmaceuticals, Inc. (2)
Paratek Pharmaceuticals, Inc. (1)
Pivot Pharmaceuticals Inc. (2)
PLAYERS NETWORK (1)
PLx Pharma Inc. (1)
PONIARD PHARMACEUTICALS, INC. (1)
ProPhase Labs, Inc. (1)
Pulmatrix, Inc. (2)
Recro Pharma, Inc. (1)
Reliant Pharmaceuticals, Inc. (1)
RELMADA THERAPEUTICS, INC. (3)
RespireRx Pharmaceuticals Inc. (1)
SALIX PHARMACEUTICALS LTD (1)
Satsuma Pharmaceuticals, Inc. (5)
SCYNEXIS INC (2)
Sucampo Pharmaceuticals, Inc. (1)
Targeted Medical Pharma, Inc. (1)
TAURIGA SCIENCES, INC. (2)
Terns Pharmaceuticals, Inc. (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
Textmunication Holdings, Inc. (1)
Theravance Biopharma, Inc. (2)
Tilray, Inc. (6)
Tongli Pharmaceuticals (USA), Inc. (2)
Vallon Pharmaceuticals, Inc. (1)
VIVUS INC (3)
Vyrix Pharmaceuticals, Inc. (2)
XANODYNE PHARMACEUTICALS INC (2)
ZOGENIX, INC. (3)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Intellectual Property Assignment Agreement by and between Apimeds Pharmaceuticals US, Inc. Apimeds Inc. and Christopher Kim, dated October 12, 2021 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Assignment Agreement by and between Apimeds Pharmaceuticals US, Inc. and Apimeds Inc., dated October 12, 2021 (Apimeds Pharmaceuticals US, Inc., Filed With SEC on September 25, 2024)
Bill of Sale and Assignment Agreement, dated as of May 28, 2024, by and between Pulmatrix, Inc. and MannKind Corporation (Pulmatrix, Inc., Filed With SEC on August 13, 2024)
Assignment and Acceptance, dated as of June 3, 2024, by and between 11065220 Canada Inc., as assignor, and Viridescent Realty Trust, Inc., as assignee (Canopy Growth Corp, Filed With SEC on June 5, 2024)
Assignment and Acceptance, dated as of June 3, 2024, by and among AFC Gamma, Inc., AFC Institutional Fund LLC and AFC Agent LLC, as assignors, and 11065220 Canada Inc., as assignee (Canopy Growth Corp, Filed With SEC on June 5, 2024)
Assignment and (ANI Pharma Inc, Filed With SEC on May 10, 2024)
Long Term International Assignment Letter, dated October 10, 2022, by and between Catalent Pharma Solutions LLC and Manja Boerman (Catalent Inc, Filed With SEC on December 8, 2023)
Form of Intellectual Property Assignment (Lowell Farms Inc., Filed With SEC on October 12, 2023)
Form of Assignment and Assumption of Contracts (Lowell Farms Inc., Filed With SEC on October 12, 2023)
Confirmatory Patent Assignment and Royalty Agreement, dated November 1, 2021, between SRQ Patent Holdings II, LLC and MIRA Pharmaceuticals, Inc (MIRA PHARMACEUTICALS, INC., Filed With SEC on June 29, 2023)
Assignment and Assumption Agreement, dated September 1, 2022, between Double Diamond Holdings Ltd., and Tilray Brands, Inc (Tilray, Inc., Filed With SEC on January 9, 2023)
Assignment and Assumption Agreement, dated June 30, 2022, between Double Diamond Holdings Ltd., and Tilray Brands, Inc (Tilray, Inc., Filed With SEC on October 7, 2022)
Amending Agreement to Amended and Restated Assignment and Assumption Agreement dated as of July 12, 2022, by and among the Company, HTI and HEXO (Tilray, Inc., Filed With SEC on July 12, 2022)
Assignment and Assumption Agreement with Pura Vida Master Fund, LTD. dated August 17, 2021 (Tilray, Inc., Filed With SEC on October 7, 2021)
Assignment and Assumption Agreement with Parallax Master Fund, L.P. dated August 17, 2021 (Tilray, Inc., Filed With SEC on October 7, 2021)
Assignment and Assumption Agreement with Gotham Green Partners, LLC dated August 17, 2021 (Tilray, Inc., Filed With SEC on October 7, 2021)
Assignment, Assumption and Novation agreement, by and among Nabriva Therapeutics Ireland Designated Activity Company, Nabriva Therapeutics GmbH, Roivant Sciences Ltd., Roivant... (Nabriva Therapeutics plc, Filed With SEC on August 5, 2021)
Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings, LLC and MyMD Pharmaceuticals, Inc (Akers Biosciences, Inc., Filed With SEC on May 18, 2021)
Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings II, LLC and Supera Pharmaceuticals, Inc (Akers Biosciences, Inc., Filed With SEC on May 18, 2021)
Patent and Know How Assignment Agreement, dated as of July 2, 2013, by and between Panoptes Pharma Ges.m.b.H and 4SC Discovery GmbH (EYEGATE PHARMACEUTICALS INC, Filed With SEC on March 25, 2021)
Assignment Agreement, dated as of June 24, 2019, by and among Terns Pharmaceuticals, Inc. and Vintagence Biotechnology Ltd (Terns Pharmaceuticals, Inc., Filed With SEC on January 15, 2021)
Patent and Patent Application Assignment Agreement between Arcturus Therapeutics, Ltd. and Vallon Pharmaceuticals, Inc., dated June 22, 2018 (Vallon Pharmaceuticals, Inc., Filed With SEC on January 14, 2021)
Patent Assignment and Option and Amended and Restated Agreement, dated June 10, 2011, between the Company and Les Laboratoires Servier (RespireRx Pharmaceuticals Inc., Filed With SEC on October 14, 2020)
ASSIGNMENT AND ASSUMPTION AGREEMENT (Bakhu Holdings, Corp., Filed With SEC on October 1, 2020)
ASSIGNMENT AND ASSUMPTION OF MEMBERSHIP INTERESTS (NewBridge Global Ventures, Inc., Filed With SEC on September 30, 2020)
Assignment and Assumption Agreement by and between the Company and Chelexa BioSciences, Inc. dated May 14, 2020 (Hoth Therapeutics, Inc., Filed With SEC on August 13, 2020)
First Amendment to Assignment Agreement, dated June 26, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Jaguar Health, Inc., Filed With SEC on August 13, 2020)
Fourth Amendment to the Amended and Restated Licensing Assignment Agreement, dated May 25, 2020, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Satsuma Pharmaceuticals, Inc., Filed With SEC on August 11, 2020)
Assignment Agreement, dated May 12, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Jaguar Health, Inc., Filed With SEC on May 21, 2020)
Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and Baudax Bio,... (Baudax Bio, Inc., Filed With SEC on November 26, 2019)
Partial Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and... (Recro Pharma, Inc., Filed With SEC on November 26, 2019)
Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,... (Bristol-Myers Squibb, Filed With SEC on November 20, 2019)
Third Amendment to the Amended and Restated Licensing and Assignment Agreement, dated October 6, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Satsuma Pharmaceuticals, Inc., Filed With SEC on August 16, 2019)
Second Amendment to Amended and Restated Licensing and Assignment Agreement, dated as of April 27, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Satsuma Pharmaceuticals, Inc., Filed With SEC on August 16, 2019)
First Amendment to Amended and Restated Licensing and Assignment Agreement, dated January 13, 2017, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical... (Satsuma Pharmaceuticals, Inc., Filed With SEC on August 16, 2019)
Amended and Restated Licensing and Assignment Agreement, dated December 16, 2016, by and between Satsuma Pharmaceuticals, Inc. and Shin Nippon Biomedical Laboratories, Ltd (Satsuma Pharmaceuticals, Inc., Filed With SEC on August 16, 2019)
Confidential Information and Invention Assignment Agreement, dated July 29, 2019, by and between Charles S. Ence and Relmada Therapeutics, Inc (RELMADA THERAPEUTICS, INC., Filed With SEC on July 29, 2019)
Founder Shares Assignment Agreement dated January 17, 2019 (Accelerated Pharma, Inc., Filed With SEC on July 24, 2019)
Founder Shares Assignment Agreement dated January 17, 2019 (Accelerated Pharma, Inc., Filed With SEC on January 25, 2019)
Confidential Information and Invention Assignment Agreement (Neuralstem, Inc., Filed With SEC on December 18, 2018)